Bioterrorism & Emerging Infectious Diseases

Planning & Preparedness


 

Agent-specific Recommendations:

 

References

English JF, Cundiff MY, Malone JD, Pfeiffer JA, Bell M, Steele L, Miller JM. Bioterrorism readiness plan: A template for healthcare facilities. Association for Professionals in Infection Control and Epidemiology and the Centers for Disease Control and Prevention, 1999.

Jernigan JA, Stephens DA, Ashford DA, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States, in press.

CDC. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001; 50: 909-940.

CDC. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR 2001; 50: 889-908.

Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon. Medical and public health management. JAMA 2000; 283: 2281-2290.

Cross JT Jr, Penn RL. Francisella tularensis (tularemia). In: Principles and Practice of Infectious Diseases, Mandell GL, Bennett JE, Dolin R, eds. Churchill Livingstone, Philadelphia PA, 2000, pp 2393-2402.

Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon. Medical and public health management. JAMA 2001; 285: 2763-2773.

Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. Medical and public health management. JAMA 1999; 281: 2127-2137.